EVALUATION FORM
2014 National TB Conference
June 11-13, 2014
1. Sign in at the Registration Desk each day on June 11 to June 13.
2. Attend the educational presentations at the meeting.
3. Complete this form and turn it in at the Registration Desk.
The 2014 National TB Conference is approved for up to 15.25 continuing education hours.
Name: ______
Email: ______Phone: ______
What type of certificate are you requesting? o CME o CNE o Participation
If CME or CNE, enter your license number: ______
What is your occupation? ______
In which sector do you work? o Public o Private
What best describes your work setting? (Check all that apply.)
o Federal agency o State agency o County agency o City agency o University
Other: ______
How long have you worked? In public health: ______years In TB: ______years
Sessions and Speakers
To evaluate each session, circle the number that reflects your agreement, disagreement, or neutrality about each statement: 1=Strongly Disagree; 2=Disagree; 3=Neutral; 4=Agree; 5=Strongly Agree.
General Session I: Defining the Vision of TB Elimination
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this presentation, participants are
able to meet these objectives:
Identify the current challenges faced by all domestic tuberculosis (TB) control programs. / 1 / 2 / 3 / 4 / 5
Communicate the vision that the Centers for Disease Control and Prevention (CDC) and the CDC’s Division of TB Elimination have outlined for the next 5 years of domestic TB control efforts. / 1 / 2 / 3 / 4 / 5
Articulate the continued role and importance of TB public health programs in the new paradigm of preventive services provided in the community under the Affordable Care Act (ACA). / 1 / 2 / 3 / 4 / 5
Describe the new paradigm of treating TB infection and the implications this new approach may have for domestic and global TB control activities. / 1 / 2 / 3 / 4 / 5
About the content:
The content was relevant to my practice. / 1 / 2 / 3 / 4 / 5
The content was free of commercial bias. / 1 / 2 / 3 / 4 / 5
About the speakers:
Jenny Flood: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Jonathon Mermin: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Dick Menzies: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
General Session II: Using Epidemiology to Inform Public Health Intervention in Key Populations
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this presentation, participants are
able to meet these objectives:
Define “sentinel populations” in TB control. / 1 / 2 / 3 / 4 / 5
Use Report of Verified Case of Tuberculosis (RVCT) data to monitor sentinel populations for TB control. / 1 / 2 / 3 / 4 / 5
Identify high-risk foreign-born populations using New York City surveillance data. / 1 / 2 / 3 / 4 / 5
Promote the understanding that TB disease and latent TB infection (LTBI) in children help define the high-risk populations in each community. / 1 / 2 / 3 / 4 / 5
Review the changes in pediatric TB demographics over the past 20 years. / 1 / 2 / 3 / 4 / 5
Use epidemiology to understand the risk of TB infection and disease among persons experiencing homelessness. / 1 / 2 / 3 / 4 / 5
Learn how housing status is associated with recent TB transmission by reviewing the epidemiology of outbreaks investigated by CDC. / 1 / 2 / 3 / 4 / 5
Understand current control practices in addressing TB among persons experiencing homelessness by sharing relevant preliminary results of a recent survey of 232 local TB programs. / 1 / 2 / 3 / 4 / 5
About the content:
The content was relevant to my practice. / 1 / 2 / 3 / 4 / 5
The content was free of commercial bias. / 1 / 2 / 3 / 4 / 5
About the speakers:
Shama Ahuja: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Ann Loeffler: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Sapna Morris: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
General Session III: From Here to Elimination: Diagnosing and Treating TB Infection
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this presentation, participants are
able to meet these objectives:
Understand that there is a spectrum of latent and active disease types of M. tuberculosis infection. / 1 / 2 / 3 / 4 / 5
Understand that the spectrum of latent infection is associated with the risk of reactivation. / 1 / 2 / 3 / 4 / 5
List the pros and cons of our current diagnostic tests. / 1 / 2 / 3 / 4 / 5
Describe strategies for prioritizing patients at highest risk for developing active TB. / 1 / 2 / 3 / 4 / 5
Describe use of short course therapy for preventing active TB. / 1 / 2 / 3 / 4 / 5
About the content:
The content was relevant to my practice. / 1 / 2 / 3 / 4 / 5
The content was free of commercial bias. / 1 / 2 / 3 / 4 / 5
About the speakers:
Philana Ling Lin: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
David Holland: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Dick Menzies: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Risa Webb: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Bob Belknap: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Meet the TB Clinicians Session
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this presentation, participants are
able to meet these objectives:
Through case studies, observe how clinicians reason through challenges in diagnosis or treatment. / 1 / 2 / 3 / 4 / 5
About the content:
The content was relevant to my practice. / 1 / 2 / 3 / 4 / 5
The content was free of commercial bias. / 1 / 2 / 3 / 4 / 5
About the panelists:
The panelists were / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
General Session IV: Applied Innovations for TB Control & Elimination
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this panel discussion, participants are
able to meet these objectives:
Define key terms and concepts related to privacy, confidentiality, and consent. / 1 / 2 / 3 / 4 / 5
Describe how privacy, confidentiality, and consent may affect the provision of TB control through electronic means. / 1 / 2 / 3 / 4 / 5
Explain how the law distinguishes between public health activities and treatment. / 1 / 2 / 3 / 4 / 5
Recognize the confidentiality and privacy issues related to the use of electronic devices for communicating with TB patients. / 1 / 2 / 3 / 4 / 5
Describe the experiences of different TB programs in leveraging technology to more efficiently communicate with patients and improve delivery of TB services. / 1 / 2 / 3 / 4 / 5
Understand the use of online social networks and web search engines to enhance case management and contact investigation activities. / 1 / 2 / 3 / 4 / 5
About the content:
The content was relevant to my practice. / 1 / 2 / 3 / 4 / 5
The content was free of commercial bias. / 1 / 2 / 3 / 4 / 5
About the speakers:
Matthew Penn: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Bruce Struminger: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Barbara Seaworth: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Lisa Trieu: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Richard Garfein: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Joshua Van Otterloo: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Elaine Darnall: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Adam Hanina: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Breakout Session 1: Innovative Uses of Genotyping in the Field to Improve TB Control
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this presentation, participants are
able to meet these objectives:
Describe the basics of genotyping for programs. / 1 / 2 / 3 / 4 / 5
Outline a model for using genotyping to predict and prevent outbreaks. / 1 / 2 / 3 / 4 / 5
Cite an example of the real-world implementation of genotyping. / 1 / 2 / 3 / 4 / 5
About the content:
The content was relevant to my practice. / 1 / 2 / 3 / 4 / 5
The content was free of commercial bias. / 1 / 2 / 3 / 4 / 5
About the speakers:
Anne Marie France: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Amit Chitnis: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Jason Cummins: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Breakout Session 2: Embracing the Stories of TB Survivors for Advocacy
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this presentation, participants are
able to meet these objectives:
List the lessons learned in the TB Voices project about engaging TB survivors. / 1 / 2 / 3 / 4 / 5
Describe the range of feelings experienced by TB survivors when approached to tell their story. / 1 / 2 / 3 / 4 / 5
Provide two examples of practical tools and mechanisms for engaging TB survivors in our work. / 1 / 2 / 3 / 4 / 5
Recognize the challenges health care providers face with finding their own voices to advocate for the TB programs and patients they serve. / 1 / 2 / 3 / 4 / 5
About the content:
The content was relevant to my practice. / 1 / 2 / 3 / 4 / 5
The content was free of commercial bias. / 1 / 2 / 3 / 4 / 5
About the speakers:
Jigna Rao: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Natalie Nelson Skipper: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Teresa Rugg: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Jon Warkentin: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Breakout Session 3: Treating MDR TB to Cure
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this presentation, participants are
able to meet these objectives:
Review resistance patterns beyond extensively drug-resistant TB (XDR TB). / 1 / 2 / 3 / 4 / 5
Analyze and interpret discrepant laboratory results in a drug-resistant TB case. / 1 / 2 / 3 / 4 / 5
Recognize global challenges in diagnosing and treating drug-resistant TB. / 1 / 2 / 3 / 4 / 5
Review the epidemiology of drug-resistant TB in the United States and recent data from the Preserving Effective TB Treatment Study (PETTS). / 1 / 2 / 3 / 4 / 5
Describe the extent of drug resistance at diagnosis among patients in the TO28 sample. / 1 / 2 / 3 / 4 / 5
List 3 things that complicate care of U.S. MDR TB patients. / 1 / 2 / 3 / 4 / 5
Describe treatment completion and mortality outcomes of the TO28 sample. / 1 / 2 / 3 / 4 / 5
Cite the average cost to the healthcare system of a patient with MDR TB and with XDR TB. / 1 / 2 / 3 / 4 / 5
Review the New York City experience of studying the TB risk and use of chemoprophylaxis for contacts exposed to multidrug-resistant TB. / 1 / 2 / 3 / 4 / 5
Describe the benefits of systematically collecting data on TB contacts. / 1 / 2 / 3 / 4 / 5
About the content:
The content was relevant to my practice. / 1 / 2 / 3 / 4 / 5
The content was free of commercial bias. / 1 / 2 / 3 / 4 / 5
About the speakers:
Caitlin Reed: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Sarita Shah: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Suzanne Marks: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Shama Ahuja: / knowledgeable on the topics covered / 1 / 2 / 3 / 4 / 5
clear and well organized / 1 / 2 / 3 / 4 / 5
Breakout Session 4: Over-consumption: Tuberculosis and Diabetes Mellitus
Strongly Disagree / Disagree / Neutral / Agree / Strongly AgreeAt the end of this presentation, participants are
able to meet these objectives:
Understand the epidemiology of TB and diabetes in the United States. / 1 / 2 / 3 / 4 / 5
Understand the impact of diabetes on TB treatment outcomes. / 1 / 2 / 3 / 4 / 5
Recognize the potential to help improve glucose control in patients with active TB. / 1 / 2 / 3 / 4 / 5